Hammond Janet MJ

CIK 00018298991 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001829899

Recent Transactions

19 trades

Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2026-01-31+58,050→ 141,801 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2026-01-31+177,000→ 177,000 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2026-01-31−11,250→ 0 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2026-01-31−46,800→ 0 total
Tax Payment
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2026-01-31$4.24/sh−14,136→ 127,665 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-31+46,800→ 84,272 total
Tax Payment
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-31$3.06/sh−14,134→ 81,388 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2025-01-31−46,800→ 46,800 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2025-01-31+11,250→ 11,250 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2025-01-31+200,000→ 200,000 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-31+11,250→ 95,522 total
Sale
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-02-01$3.84/sh−14,029→ 35,362 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2024-01-31+225,200→ 225,200 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-01-31+46,800→ 49,391 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2024-01-31−46,800→ 93,600 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2023-01-31+140,400→ 140,400 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2023-01-31+196,600→ 196,600 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2022-01-31+190,000→ 190,000 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2021-01-29+160,050→ 160,050 total

Companies

Atea Pharmaceuticals, Inc.
Chief Development Officer
$AVIR

Recent Filings

Address

225 FRANKLIN STREET SUITE 2100

BOSTON, MA, 02110

View on SEC.gov